CVIR Endovascular · Published 2026-07-29 · DOI 10.1186/s42155-026-00742-3
Hiroyuki Tokue, Masashi Ebara, Azusa Tokue, Yoshito Tsushima
Abstract Background/objectives Although inferior epigastric artery (IEA)-related hemorrhage can occur in diverse settings, outcomes following transcatheter arterial embolization (TAE) vary according to collateral anatomy and physiologic severity. We aimed to describe a collateral-pathway–oriented clinico-angiographic framework for IEA-related hemorrhage and evaluate technical and clinical outcomes of TAE across these categories. Predictors of the composite clinical failure endpoint and a simple exploratory descriptive score were assessed as exploratory secondary analyses. Methods We retrospectively reviewed 62 consecutive patients with IEA-related hemorrhagic events treated with TAE; cases were categorized into four collateral-pathway–oriented clinico-angiographic categories (Types A–D) based on CT/DSA findings together with the clinical context, to reflect the dominant collateral circuit relevant to embolization planning. The categories were Type A (isolated abdominal wall, n = 28), Type B (round ligament/postpartum, n = 15), Type C (corona mortis/pelvic fracture, n = 16), and Type D (iatrogenic puncture-related, n = 3). Technical success was defined as angiographic disappearance of the extravasation/pseudoaneurysm. Clinical success was defined as hemodynamic stabilization within 24 h without repeat TAE or surgery. Clinical failure comprised lack of clinical success and/or in-hospital death. Rebleeding from the treated IEA territory was also assessed separately. Logistic regression was performed after excluding Type D patients (n = 59) owing to complete separation as an exploratory analysis of factors associated with the composite clinical failure endpoint. A point-based score was derived descriptively from these factors. Results Technical success was achieved in all cases (62/62, 100%). The overall clinical success rate was 82.3% (51/62). Clinical success rates varied across categories: Type A 96.4%; Type B, 80.0%; Type C, 56.3%; and Type D, 100%. Rebleeding from the treated IEA territory occurred in 3 patients (4.8%), all of whom had Type C. In-hospital mortality was 12.9% (8/62), concentrated in Type C. In exploratory multivariable analysis (n = 59), Type C category (aOR, 4.6), DIC (aOR, 3.7), and SBP < 80 mmHg (aOR, 3.1) were associated with the composite clinical failure endpoint. A descriptive three-factor score (Type C = 2, DIC = 2, and SBP < 80 mmHg = 1) showed a stepwise increase in this composite endpoint from 7.1 to 71.4%. Conclusions A collateral-pathway–oriented clinico-angiographic framework may support systematic evaluation of the external iliac/IEA system during embolization planning. Poorer outcomes in pelvic fracture–related Type C cases should be interpreted cautiously because they may reflect trauma burden, coagulopathy, and systemic derangement rather than IEA embolization failure alone.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Tokue, H., Ebara, M., Tokue, A., et al. (2026). Collateral-pathway–oriented clinico-angiographic framework for inferior epigastric artery–related hemorrhage: embolization planning and clinical outcomes. CVIR Endovascular. https://doi.org/10.1186/s42155-026-00742-3